tirzepatide for children Medscape - The SURPASS-PEDS trial shows delivers durable glycemic control and weight benefit in youth with type 2 diabetes, the first therapy to show this effect. http://ms.spr.ly/6180sWS1i Big update in pediatric diabetes

It can also lower vitamin B12 levels over time and may increase the risk of low blood sugar if taken with insulin or similar meds

Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations

A registered dietitian can help you optimize your nutrition and energy levels with a personalized plan that fits your lifestyle

The page is built around patient education and clinical context, with the highest-value checks sitting around semaglutide, cost and coverage, provider access, safety and pharmacy quality